The emerging roles and therapeutic potential of cyclin-dependent kinase 11 (CDK11) in human cancer
Yubing Zhou(First Affiliated Hospital of Zhengzhou University), Zhenfeng Duan(Sylvester Comprehensive Cancer Center)
Cited by 74
Related Papers
Targeting Cdk11 in osteosarcoma cells using the CRISPR‐cas9 system
|Journal of Orthopaedic Research®|2014|106
Targeting <i>ABCB1 (MDR1)</i> in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance
|Oncotarget|2016|88
Cyclin-dependent kinase 11p110 (CDK11p110) is crucial for human breast cancer cell proliferation and growth
|Scientific Reports|2015|75
SD-1029 Inhibits Signal Transducer and Activator of Transcription 3 Nuclear Translocation
|Clinical Cancer Research|2006|67
Cyclin E1 is a prognostic biomarker and potential therapeutic target in osteosarcoma
|Journal of Orthopaedic Research®|2020|30